CD44 (HCAM) expression in subserous gallbladder carcinoma;Expresión de CD44 (HCAM) en el carcinoma subseroso de la vesícula biliar

Revista Medica de Chile

Volumn 129, Issue 7, 2001, Pages 727-734

  Roa E, Iván ^a,b   Villaseca H, Miguel ^a   Araya O, Juan ^a   Roa S, Juan ^a   De Aretxabala U, Xabier ^a   Ibacache S, Gilda ^a   García V, Marcela ^a  

^a UNIVERSIDAD DE LA FRONTERA   (Chile)

^b NONE   (Chile)

Author keywords

Antigens; Carcinoma; CD44; Gallbladder neoplasm

Indexed keywords

HERMES ANTIGEN; TUMOR ANTIGEN; TUMOR MARKER;

ADENOCARCINOMA; ADULT; AGED; ARTICLE; FEMALE; FOLLOW UP; GALLBLADDER TUMOR; HUMAN; IMMUNOLOGY; MALE; METABOLISM; MIDDLE AGED; PATHOLOGY; PROGNOSIS; SEROSA; SURVIVAL;

ADENOCARCINOMA; ADULT; AGED; AGED, 80 AND OVER; ANTIGENS, CD44; ANTIGENS, NEOPLASM; FEMALE; FOLLOW-UP STUDIES; GALLBLADDER NEOPLASMS; HUMANS; MALE; MIDDLE AGED; PROGNOSIS; SEROUS MEMBRANE; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 0035404498     PISSN: 00349887     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (34)

1. MEDINA E. Las enfermedades digestivas en Chile: Panorama epidemiológico. Rev Méd Chile 1988; 166: 282-8.
2. ROA I, ARAYA J, WISTUBA I, DE ARETXABALA X. Cáncer de la vesícula biliar. Consideraciones anatómicas y anatomopatológicas. Rev Méd Chile 1990; 118: 572-9.
3. CHIANALE J, VALDIVIA G, DEL PINO G, NERVI F. Mortalidad por cáncer de la vesícula biliar en Chile y su relación con las tasas de colecistectomía. Análisis de la última década. Rev Méd Chile 1990; 118: 1284-8.
4. GARRIDO L, DE ARETXABALA X, ROA I, BURGOS L. Análisis de factores pronósticos en el cáncer de la vesícula biliar con infiltración de la subserosa. Rev Chil Cir 1996; 48: 483-9.
5. DE ARETXABALA X, ROA I, BURGOS L, CARTES R, SILVA J, YÁÑEZ E, ARAYA JC, VILLASECA M, QUIJADA I, VITTINI C. Preoperative chemoradiotherapy in the treatment of gallbladder cancer. Am Surg 1999; 65: 241-6.
6. DE ARETXABALA X, ROA I, BURGOS L. Gallbladder cancer, management of early tumors. Hepatogastroenterology 1999; 46: 1547-51.
7. KEMENY MM. Is there a role for radical surgery in advanced gallbladder carcinoma? HPB-Surg 1997; 10: 335-8.
8. KUROKAWA T, NONAMI T, NAKAO A, OKUDA N, HARADA A, TAKAGI H. The role of extended radical procedures in advanced gallbladder cancer. Hepatogastroenterology 1999; 46: 1561-6.
9. MENGER M, VOLLMAR B. Adhesion molecules as determinants of disease: from molecular biology to surgical research. Br J Surg 1996; 83: 588-601.
10. FRENETTE P, WAGNER D. Adhesion molecules part II: Blood vessels and blood cells. N Engl J Med 1996; 334: 1526-9.
11. JIANG W, PUNTIS M, HALLETT M. Molecular and cellular basis of cancer invasion and metastasis: Implications for treatment. Br J Surg 1996; 83: 1576-90.
12. PETRUZZELLI L, TAKAMI M, HUMES HD. Structure and function of cell adhesion molecules. Am J Med 1999; 106: 467-76.
13. JAWHARI A, JORDAN S, POOLE S, BROWNE P, PIGNATELLI M, FARTHING M. Abnormal immunoreactivity of the E-Cadherin-Catenin complex in gastric carcinoma: relationship with patient survival. Gastroenterology 1997; 112: 46-54.
14. PAUL R, EWING C, JARRAD D, ISAACS W. The cadherin cell-cell adhesion pathway in prostate cancer progression. Br J Urol 1997; 79 sup 1: 37-43.
15. CHARPIN C, GARCÍA S, BONNIER P, MARINI F, ANDRAC L, CHOUX R, LAVAUT M, ALLASIA C. Reduced E-cadherin immunohistochemical expression in node negative breast carcinomas correlates with 10 years survival. Am J Clin Pathol 1998; 109: 431-8.
16. CARICO E, FRENCH D, BUCCI B, FALCIONI R, VECCHIONE A, MARIANI R. Integrin beta-4 expression in the neoplastic progression of cervical epithelium. Gynecol Oncol 1993; 49: 61-6.
17. HAIER J, NASRALLA M, NICOLSON GL. Cell surface molecules and their prognostic values in assessing colorectal carcinomas. Ann Surg 2000; 231: 11-24.
18. FAVROT MC, COMBARET V, LASSET C. CD44 a new prognostic marker for neuroblastoma. N Engl J Med 1993; 329: 1965.
19. RUDZKI Z, JOTHY S. CD 44 and the adhesion of neoplastic cells. J Clin Pathol Mol Pathol 1997; 50: 57-71.
20. NAOT D, SIONOV RV, ISH-SHALOM D. CD44: structure, function and association with the malignant process. Adv Cancer Res 1997; 71: 241-319.
21. SNEATH RJ, MANGHAM DC. The normal structure and function of CD44 and its role in neoplasia. Mol Pathol 1998; 51: 191-200.
22. GOODISON S, TARIN D. Current status of CD44 variant isoforms as cancer diagnostic markers. Histopatbology 1998; 32: 1-6.
23. LIU D, LIU T, LI R, SY MS. Mechanisms regulating the binding activity of CD44 to hyaluronic acid. Front Biosci 1998; 3: 631-6.
24. PONTA H, WAINWRIGHT D, HERRLICH P. The CD44 protein family. Int J Biochem Cell Biol 1998; 30: 299-305.
25. LESLEY J, HYMAN R, KINCADE PW. CD44 and its interaction with extracellular matrix. Adv Immunol 1993; 54: 271-335.
26. HERRERA-GAYOL A, JOTHY S. Adhesion proteins in the biology of breast cancer: contribution of CD44. Exp Mol Pathol 1999; 66: 149-56.
27. GHUNTER U, HOFMANN M, RUDY W, REBER S, ZOLLER M, HAUSMANN I. A new variant of glycoprotein CD44 confers metastatic potential to rat carcinoma cells. Cell 1991; 65: 13-24.
28. SEITER S, ARCH R, REBER R, ZOLLER M, HAUSMANN I. Prevention of tumor metastasis by antivariant CD44. J Exp Med 1993; 177: 43-5.
29. BOURRGUIGNON LY, IIDA N, WELSH CF, ZHU D, KRONGRAD A, PASQUALE D. Involvement of CD44 and its variant isoforms in membrane-cytoskeleton interaction, cell adhesion and tumor metastasis. J Neurooncol 1995; 26: 201-8.
30. MULDER JW, WIELENGA VJ, POLAK MM, VAN DEN BERG FM, ADOLF GR, HERRLICH P, PALS ST, OFFERHAUS GJ. Expression of mutant p53 protein and CD44 variant proteins in colorectal tumorigenesis. Gut 1995; 36: 76-80.
31. YAMAGUCHI A, ZHANG M, GOI T, FUJITA T, NIIMOTO S, KATAYAMA K, HIROSE K. Expression of variant CD44 containing variant exon v8-10 in gallbladder. Cancer Oncol Rep 2000; 7: 541-4.
32. ASHIDA K, TERADA T, KITAMURA Y, KAIBARA N. Expression of E-cadherin, alpha catenin, beta catenin and CD44 (standard and variant isoforms) in human cholangiocarcinoma: an immunohistochemical study. Hepatology 1998; 27: 974-82.
33. ROA I, ARAYA JC, VILIASECA M, ROA J, DE ARETXABALA X, IBACACHE G. Gallbladder cancer in a high risk area: morphological features and spread patterns. Hepatogastroenterology 1999; 46: 1540-6.
34. GOTODA T, MATSUMURA Y, KONDO H, ONO H, KANAMOTO A, KATO H, WATANABE H, TACHIMORI Y, NAKANISHI Y, KAKIZOE T. Expression of CD44 variants and prognosis in oesophageal squamous cell carcinoma. Gut 2000; 46: 14-9.